For distribution only in markets where the Symplicity renal denervation system is approved. Not for distribution in the USA or Japan. Trademarks may be re

istered and are the property of their respective owners. ! "#$" %edtronic& 'nc. All ri

hts reserved. U("#$"#))*+,, -enal .enervation Suku Thambar ccFor distribution only in markets where the Symplicity renal denervation system is approved. Not for distribution in the USA or Japan. Trademarks may be re

istered and are the property of their respective owners. ! "#$" %edtronic& 'nc. All ri

hts reserved. U("#$"#))*+,,/ypertension ,pidemioloy0 Sinle larest contributor to death worldwide0 ,very "#1$# mm/ increase in 23 correlates with a doublin of $#4year cardiovascular mortality0 .ramatically increases risk of stroke& heart attack& heart failure& 5 kidney failure0 6nly half of all treated hypertensives are controlled to established 23 tarets0 /ih prevalence70 Affects $ in 8 adults0 $2 people worldwide $.* 2 by "#")35%Treated &Controlled30% Untreated35% Treated but Uncontrolled(hobanian et al. /ypertension."##89:";*rum& /.